Download
s00430-020-00698-8.pdf 1,16MB
WeightNameValue
1000 Titel
  • Evaluation of two rapid antigen tests to detect SARS-CoV-2 in a hospital setting
1000 Autor/in
  1. Osterman, Andreas |
  2. Baldauf, Hanna-Mari |
  3. Eletreby, Marwa |
  4. Wettengel, Jochen M. |
  5. Afridi, Suliman Q. |
  6. Fuchs, Thimo |
  7. Holzmann, Elena |
  8. Maier, Anton |
  9. Döring, Johanna |
  10. Grzimek-Koschewa, Natascha |
  11. Muenchhoff, Maximilian |
  12. Protzer, Ulrike |
  13. Kaderali, Lars |
  14. Keppler, Oliver T |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-01-16
1000 Erschienen in
1000 Quellenangabe
  • 210(1):65-72
1000 Copyrightjahr
  • 2021
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00430-020-00698-8 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7811156/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Successful containment strategies for the SARS-CoV-2 pandemic will depend on reliable diagnostic assays. Point-of-care antigen tests (POCT) may provide an alternative to time-consuming PCR tests to rapidly screen for acute infections on site. Here, we evaluated two SARS-CoV-2 antigen tests: the STANDARD™ F COVID-19 Ag FIA (FIA) and the SARS-CoV-2 Rapid Antigen Test (RAT). For diagnostic assessment, we used a large set of PCR-positive and PCR-negative respiratory swabs from asymptomatic and symptomatic patients and health care workers in the setting of two University Hospitals in Munich, Germany, i.e. emergency rooms, patient care units or employee test centers. For FIA, overall clinical sensitivity and specificity were 45.4% (n = 381) and 97.8% (n = 360), respectively, and for RAT, 50.3% (n = 445) and 97.7% (n = 386), respectively. For primary diagnosis of asymptomatic and symptomatic individuals, diagnostic sensitivities were 60.9% (FIA) (n = 189) and 64.5% (RAT) (n = 256). This questions these tests' utility for the reliable detection of acute SARS-CoV-2-infected individuals, in particular in high-risk settings. We support the proposal that convincing high-quality outcome data on the impact of false-negative and false-positive antigen test results need to be obtained in a POCT setting. Moreover, the efficacy of alternative testing strategies to complement PCR assays must be evaluated by independent laboratories, prior to widespread implementation in national and international test strategies.
1000 Sacherschließung
lokal COVID-19/diagnosis [MeSH]
lokal Diagnostic test
gnd 1206347392 COVID-19
lokal COVID-19/immunology [MeSH]
lokal Point-of-Care Systems [MeSH]
lokal Adult [MeSH]
lokal Humans [MeSH]
lokal Specificity
lokal COVID-19 Serological Testing/methods [MeSH]
lokal False Positive Reactions [MeSH]
lokal SARS-CoV-2 antigen test
lokal SARS-CoV-2/isolation
lokal Original Investigation
lokal Sensitivity and Specificity [MeSH]
lokal Antigens, Viral/blood [MeSH]
lokal SARS-CoV-2/immunology [MeSH]
lokal Germany [MeSH]
lokal Sensitivity
lokal False Negative Reactions [MeSH]
lokal Child [MeSH]
lokal COVID-19 point-of-care
lokal Child, Preschool [MeSH]
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/T3N0ZXJtYW4sIEFuZHJlYXM=|https://frl.publisso.de/adhoc/uri/QmFsZGF1ZiwgSGFubmEtTWFyaQ==|https://frl.publisso.de/adhoc/uri/RWxldHJlYnksIE1hcndh|https://frl.publisso.de/adhoc/uri/V2V0dGVuZ2VsLCBKb2NoZW4gTS4=|https://frl.publisso.de/adhoc/uri/QWZyaWRpLCBTdWxpbWFuIFEu|https://frl.publisso.de/adhoc/uri/RnVjaHMsIFRoaW1v|https://frl.publisso.de/adhoc/uri/SG9sem1hbm4sIEVsZW5h|https://frl.publisso.de/adhoc/uri/TWFpZXIsIEFudG9u|https://frl.publisso.de/adhoc/uri/RMO2cmluZywgSm9oYW5uYQ==|https://frl.publisso.de/adhoc/uri/R3J6aW1lay1Lb3NjaGV3YSwgTmF0YXNjaGE=|https://frl.publisso.de/adhoc/uri/TXVlbmNoaG9mZiwgTWF4aW1pbGlhbg==|https://frl.publisso.de/adhoc/uri/UHJvdHplciwgVWxyaWtl|https://frl.publisso.de/adhoc/uri/S2FkZXJhbGksIExhcnM=|https://orcid.org/0000-0002-1384-8946
1000 Hinweis
  • DeepGreen-ID: d224a1dd61074534a78c04aaedd8331d ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6449986.rdf
1000 Erstellt am 2023-05-09T10:50:02.429+0200
1000 Erstellt von 322
1000 beschreibt frl:6449986
1000 Zuletzt bearbeitet Sat Oct 21 02:32:19 CEST 2023
1000 Objekt bearb. Sat Oct 21 02:32:19 CEST 2023
1000 Vgl. frl:6449986
1000 Oai Id
  1. oai:frl.publisso.de:frl:6449986 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source